Document Detail


NDM-4 metallo-ss-lactamase with increased carbapenemase activity from Escherichia coli.
MedLine Citation:
PMID:  22252797     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A clinical Escherichia coli isolate resistant to all β-lactams including carbapenems expressed a novel metallo-β-lactamase (MBL) NDM-4 differing from NDM-1 by a single amino acid substitution (Met154Leu). NDM-4 possessed increased hydrolytic activity toward carbapenems and several cephalosporins as compared to NDM-1. This amino-acid substitution was not located into the known active sites of NDM-1 indicating that remote amino-acid subtitutions might also play a role in the extended activity of this MBL.
Authors:
Patrice Nordmann; Anne E Boulanger; Laurent Poirel
Related Documents :
6201097 - Comparison of the amino acid compositions and antigenic properties of spiralins purifie...
18155317 - Preliminary study on biomarkers for the fungal resistance in vitis vinifera leaves.
16665397 - Development at cold-hardening temperatures : the structure and composition of purified ...
22093837 - Novel multi-component enzyme machinery in lactic acid bacteria catalyzing cc double bon...
701287 - Mechanism of luteinizing hormone regulation of prostaglandin synthesis in rat granulosa...
8460917 - In vitro activities of ceftriaxone and fusidic acid against 13 isolates of coxiella bur...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-17
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  -     ISSN:  1098-6596     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Service de Bactériologie-Virologie, INSERM U914 « Emerging Resistance to Antibiotics », Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine et Université Paris-Sud, K.-Bicêtre.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety pr...
Next Document:  Population Pharmacokinetics of Telavancin in Healthy Subjects and Patients with Infections.